Review
Aug 2026
De-escalation of perioperative systemic therapy for early breast cancer.
Current evidence and ongoing studies on treatment de-escalation across breast cancer subtypes are summarized and integration of molecular biomarkers with response-adapted strategies may further refine risk stratification and support personalized treatment approaches.
M. Ono, Y. Sagara, Toshiyuki Ishiba et al.
· Japanese Journal of Clinical... · 0 citations